S&P 500
(0.34%) 5 117.12 points
Dow Jones
(0.31%) 38 356 points
Nasdaq
(0.38%) 15 988 points
Oil
(-0.86%) $83.13
Gas
(5.82%) $2.04
Gold
(0.43%) $2 357.40
Silver
(0.46%) $27.66
Platinum
(3.92%) $958.25
USD/EUR
(-0.22%) $0.933
USD/NOK
(-0.37%) $10.98
USD/GBP
(-0.54%) $0.796
USD/RUB
(1.66%) $93.40

リアルタイムの更新: PetIQ Inc [PETQ]

取引所: NASDAQ セクター: Healthcare 産業: Drug Manufacturers—Specialty & Generic
BUY
50.00%
return 1.99%
SELL
25.00%
return 2.81%
最終更新日時30 4月 2024 @ 01:36

0.24% $ 16.57

売る 109180 min ago

@ $17.87

発行日: 14 2月 2024 @ 05:58


リターン: -7.27%


前回のシグナル: 2月 13 - 23:30


前回のシグナル: 買う


リターン: -1.05 %

Live Chart Being Loaded With Signals

Commentary (30 4月 2024 @ 01:36):
Profile picture for PetIQ Inc

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services...

Stats
本日の出来高 46 692.00
平均出来高 304 245
時価総額 488.54M
EPS $0 ( 2024-02-28 )
次の収益日 ( $0 ) 2024-05-07
Last Dividend $0 ( N/A )
Next Dividend $0 ( N/A )
P/E 236.71
ATR14 $0.0190 (0.11%)
Insider Trading
Date Person Action Amount type
2024-03-12 Christensen Mccord Buy 5 680 Class A Common Stock
2024-03-12 Christensen Mccord Sell 2 236 Class A Common Stock
2024-03-12 Christensen Mccord Sell 5 680 Restricted Stock Unit
2024-03-12 Smith Michael A Buy 1 581 Class A Common Stock
2024-03-12 Smith Michael A Sell 714 Class A Common Stock
INSIDER POWER
49.82
Last 99 transactions
Buy: 1 116 608 | Sell: 323 106

ボリューム 相関

長: -0.10 (neutral)
短: 0.46 (neutral)
Signal:(57.489) Neutral

PetIQ Inc 相関

10 最も正の相関
10 最も負の相関

知っていましたか?

相関は、2つの変数間の関係を説明する統計的指標です。相関係数は-1から1までの値を取り、-1は完全な負の相関(1つの変数が増加すると、もう一方は減少する)、1は完全な正の相関(1つの変数が増加すると、もう一方も増加する)、0は相関がないことを示します(変数間に関係がない)。

相関は、株式だけでなく、どの2つの変数間の関係にも適用できます。これは、金融、経済学、心理学などの分野で一般的に使用されています。

PetIQ Inc 相関 - 通貨/商品

The country flag -0.13
( neutral )
The country flag -0.17
( neutral )
The country flag 0.00
( neutral )
The country flag -0.17
( neutral )
The country flag 0.87
( strong )
The country flag 0.05
( neutral )

PetIQ Inc 財務諸表

Annual 2023
収益: $1.10B
総利益: $252.74M (22.94 %)
EPS: $0.0731
FY 2023
収益: $1.10B
総利益: $252.74M (22.94 %)
EPS: $0.0731
FY 2022
収益: $921.51M
総利益: $209.66M (22.75 %)
EPS: $-1.670
FY 2021
収益: $932.53M
総利益: $186.39M (19.99 %)
EPS: $-0.570

Financial Reports:

No articles found.

PetIQ Inc

PetIQ, Inc. operates as a pet medication and wellness company in the United States and internationally. It operates in two segments, Products and Services. The company offers Rx pet medications, which include flea and tick control, heartworm preventatives, arthritis, thyroid, diabetes and pain treatments, antibiotics, and other specialty medications; and develops and manufactures its own proprietary value-branded products, as well as distributes third-party branded medications. It also provides OTC medications and supplies primarily within the flea and tick control, and behavior management categories of the health and wellness industry in various forms, such as spot on (topical) treatments, chewables, oral tablets, and collars. In addition, the company offers health and wellness products that include dental treats and nutritional supplements, which comprise hip and joint, vitamins, and skin and coat products. The company provides its products primarily under the PetIQ, PetArmor, VIP Petcare, VetIQ PetCare, VetIQ, Capstar, Advecta, SENTRY, Sergeants, PetLock, Heart Shield Plus, TruProfen, Betsy Farms, PetAction, Minties, Vera, and Delightibles brands. In addition, the company offers a suite of services at 2,900 community clinics and wellness centers hosted at pet retailers across 42 states, including diagnostic tests, vaccinations, prescription medications, microchipping, and wellness checks. It operates through approximately 60,000 points of distribution across veterinarian, retail, and e-commerce channels. The company was founded in 2010 and is headquartered in Eagle, Idaho.

について ライブシグナル

このページで提示されるライブシグナルは、NA を買う時や売る時を判断するのに役立ちます。シグナルには1分以上の遅延があります。市場シグナルには誤りやミスの可能性があるため、ライブ取引シグナルは決定的ではなく、getagraph.comはこれらのシグナルに基づく任意の行動について責任を負いません。詳細については、利用規約で説明されているように、技術分析指標に基づいています。